American International Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

American International Group’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,099	Closed	-$31K	–	3330
2022 Q1	$31K	Sell	1,099 -77	-7%	-$2.8K	﹤0.01%	2974
2021 Q4	$53K	Sell	1,176 -35	-3%	-$2.35K	﹤0.01%	2943
2021 Q3	$101K	Sell	1,211 -29	-2%	-$2.4K	﹤0.01%	2807
2021 Q2	$118	Buy	+1,240	New	+$147K	﹤0.01%	2819
2019 Q2	–	Sell	-23	Closed	-$4K	–	3171
2019 Q1	$4K	Sell	23 -1	-4%	-$149	﹤0.01%	3046
2018 Q4	$3K	Hold	24	–	–	﹤0.01%	3078
2018 Q3	$5K	Buy	24 +3	+14%	+$7.2K	﹤0.01%	3165
2018 Q2	$46K	Buy	+21	New	+$53.3K	﹤0.01%	3003
2016 Q2	–	Sell	-1	Closed	-$1K	–	4586
2016 Q1	$1K	Hold	1	–	–	﹤0.01%	4976
2015 Q4	$1K	Hold	1	–	–	﹤0.01%	4948
2015 Q3	$1K	Buy	+1	New	+$1.46K	﹤0.01%	4924
2014 Q2	–	Sell	-13	Closed	-$27.3K	–	5049
2014 Q1	$27.3K	Buy	13 +1	+8%	+$2.49K	﹤0.01%	4078
2013 Q4	$28.7K	Sell	12 -2	-14%	-$4.58K	﹤0.01%	3990
2013 Q3	$39.4K	Hold	14	–	–	﹤0.01%	3836
2013 Q2	$133K	Buy	+14	New	+$108K	﹤0.01%	2903

Other funds holding ONCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QPW

Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

American International Group's ONCT Position: Q2 2022 in Review

American International Group sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2022, closing a stake of 1,099 shares — an estimated $31K sold.

American International Group first reported a position in ONCT in Q2 2013 and held it in 15 quarters. The position peaked at $133K in Q2 2013. 75 funds tracked by Wall St. Rank hold ONCT as of Q2 2022.

American International Group reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
American International Group sold 1,099 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $31K.
American International Group first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
American International Group's Oncternal Therapeutics, Inc. Common Stock position peaked at $133K in Q2 2013.
75 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.